496 related articles for article (PubMed ID: 26453964)
1. CNS remyelination as a novel reparative approach to neurodegenerative diseases: The roles of purinergic signaling and the P2Y-like receptor GPR17.
Fumagalli M; Lecca D; Abbracchio MP
Neuropharmacology; 2016 May; 104():82-93. PubMed ID: 26453964
[TBL] [Abstract][Full Text] [Related]
2. Abnormal Upregulation of GPR17 Receptor Contributes to Oligodendrocyte Dysfunction in SOD1 G93A Mice.
Bonfanti E; Bonifacino T; Raffaele S; Milanese M; Morgante E; Bonanno G; Abbracchio MP; Fumagalli M
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244295
[TBL] [Abstract][Full Text] [Related]
3. The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair.
Lecca D; Trincavelli ML; Gelosa P; Sironi L; Ciana P; Fumagalli M; Villa G; Verderio C; Grumelli C; Guerrini U; Tremoli E; Rosa P; Cuboni S; Martini C; Buffo A; Cimino M; Abbracchio MP
PLoS One; 2008; 3(10):e3579. PubMed ID: 18974869
[TBL] [Abstract][Full Text] [Related]
4. UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
Coppi E; Maraula G; Fumagalli M; Failli P; Cellai L; Bonfanti E; Mazzoni L; Coppini R; Abbracchio MP; Pedata F; Pugliese AM
Glia; 2013 Jul; 61(7):1155-71. PubMed ID: 23640798
[TBL] [Abstract][Full Text] [Related]
5. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
6. Regulation and signaling of the GPR17 receptor in oligodendroglial cells.
Lecca D; Raffaele S; Abbracchio MP; Fumagalli M
Glia; 2020 Oct; 68(10):1957-1967. PubMed ID: 32086854
[TBL] [Abstract][Full Text] [Related]
7. Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination.
Coppolino GT; Marangon D; Negri C; Menichetti G; Fumagalli M; Gelosa P; Dimou L; Furlan R; Lecca D; Abbracchio MP
Glia; 2018 May; 66(5):1118-1130. PubMed ID: 29424466
[TBL] [Abstract][Full Text] [Related]
8. G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Differentiation in Response to Lysolecithin-Induced Demyelination.
Lu C; Dong L; Zhou H; Li Q; Huang G; Bai SJ; Liao L
Sci Rep; 2018 Mar; 8(1):4502. PubMed ID: 29540737
[TBL] [Abstract][Full Text] [Related]
9. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Burnstock G
Neuropharmacology; 2016 May; 104():4-17. PubMed ID: 26056033
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A₂A receptors inhibit delayed rectifier potassium currents and cell differentiation in primary purified oligodendrocyte cultures.
Coppi E; Cellai L; Maraula G; Pugliese AM; Pedata F
Neuropharmacology; 2013 Oct; 73():301-10. PubMed ID: 23770463
[TBL] [Abstract][Full Text] [Related]
11. Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.
Ou Z; Sun Y; Lin L; You N; Liu X; Li H; Ma Y; Cao L; Han Y; Liu M; Deng Y; Yao L; Lu QR; Chen Y
J Neurosci; 2016 Oct; 36(41):10560-10573. PubMed ID: 27733608
[TBL] [Abstract][Full Text] [Related]
12. Nerve impulses regulate myelination through purinergic signalling.
Fields RD
Novartis Found Symp; 2006; 276():148-58; discussion 158-61, 233-7, 275-81. PubMed ID: 16805428
[TBL] [Abstract][Full Text] [Related]
13. The role of the adenosinergic system in lung fibrosis.
Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
[TBL] [Abstract][Full Text] [Related]
14. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
15. Expression of the new P2Y-like receptor GPR17 during oligodendrocyte precursor cell maturation regulates sensitivity to ATP-induced death.
Ceruti S; Viganò F; Boda E; Ferrario S; Magni G; Boccazzi M; Rosa P; Buffo A; Abbracchio MP
Glia; 2011 Mar; 59(3):363-78. PubMed ID: 21264945
[TBL] [Abstract][Full Text] [Related]
16. [Recently identified GPR17 receptors--characteristics and role in pathology of the nervous system].
Wypych D
Postepy Biochem; 2014; 60(4):514-24. PubMed ID: 25807830
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine.
Fumagalli M; Lecca D; Coppolino GT; Parravicini C; Abbracchio MP
Adv Exp Med Biol; 2017; 1051():169-192. PubMed ID: 28828731
[TBL] [Abstract][Full Text] [Related]
18. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
[TBL] [Abstract][Full Text] [Related]
19. The G Protein-Coupled Receptor GPR17: Overview and Update.
Marucci G; Dal Ben D; Lambertucci C; Santinelli C; Spinaci A; Thomas A; Volpini R; Buccioni M
ChemMedChem; 2016 Dec; 11(23):2567-2574. PubMed ID: 27863043
[TBL] [Abstract][Full Text] [Related]
20. A new role for the P2Y-like GPR17 receptor in the modulation of multipotency of oligodendrocyte precursor cells in vitro.
Boccazzi M; Lecca D; Marangon D; Guagnini F; Abbracchio MP; Ceruti S
Purinergic Signal; 2016 Dec; 12(4):661-672. PubMed ID: 27544384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
